Min.Order / FOB Price:Get Latest Price
0 Metric Ton |
Negotiable |
9004-54-0 Factory supply Best purity 99% API USP/EP Dextran 40/5/20/70 CAS 9004-54-0 Leading GMP producer Factory supply Best purity 99% API USP/EP Dextran 40/5/20/70 CAS 9004-54-0 Leading GMP producer
Product Description
Item |
Standard |
|
Structural data confirmation |
1. H-NMR: The data of structure are identical with reference standard |
|
2. HPLC-MS: Ensure the molecular weight of main peak and fragment peak are identical with reference standard |
||
3. IR:The data of IR are identical with that of reference standard |
||
Purity(HPLC) |
≥99.0% |
|
Related impurities |
Specific single impurity |
Meets EP/USP/BP standards |
Non-specific single impurity |
≤0.10% |
|
Total Impurities |
≤0.50% |
|
Crystal form |
Meets EP/USP/BP standards |
|
Loss on drying |
≤1.0% |
|
Water |
≤1.0% |
|
Inorganic salt |
≤0.1% |
|
Heavy metals |
≤10 ppm |
|
Assay |
99.0%~101.0%(According to EP/USP/BP standards) |
|
Microbiological Analysis |
||
Total plate count |
≤1000cfu/g |
|
Yeast and Moulds |
≤100cfu/g |
|
E. Coli. |
Absent |
|
Salmonella |
Absent |
|
S.aureus |
Absent |
Shelf Life | 2 years |
Stock | In stock |
Packaging | 25kgs/Drum |
Certification | GMP/DMF/ISO |
Test standard | EP/USP/BP |
Test Method | HPLC/UV |
Assay Result | 99.0%~101.0% |
Application:
Anti-anemia drugs. For iron deficiency anemia.
Adverse reactions and contraindications After the injection of this product, hemoglobin did not increase gradually, and should be discontinued. Liver and kidney dysfunction are hanged.
Blood volume supplements.
Adverse reactions and contraindications Occasional allergic reactions. Patients with congestive heart failure and bleeding disorders should be banned, and those with heart, liver and kidney dysfunction should be used with caution.
The medium molecular dextran is mainly used to increase plasma volume and maintain blood pressure, mainly anti-shock. It is suitable for supplementing blood volume and maintaining blood pressure when a large amount of blood is lost. Hemorrhagic such as burns, trauma, trauma, etc. and first aid caused by excessive blood loss. Low molecular dextran, mainly to improve microcirculation, to prevent or eliminate intravascular red blood cell aggregation and thrombosis. The action and use of small molecule dextran is similar to that of a low molecular dextran machine.
Item |
Standard |
|
Structural data confirmation |
1. H-NMR: The data of structure are identical with reference standard |
|
2. HPLC-MS: Ensure the molecular weight of main peak and fragment peak are identical with reference standard |
||
3. IR:The data of IR are identical with that of reference standard |
||
Purity(HPLC) |
≥99.0% |
|
Related impurities |
Specific single impurity |
Meets EP/USP/BP standards |
Non-specific single impurity |
≤0.10% |
|
Total Impurities |
≤0.50% |
|
Crystal form |
Meets EP/USP/BP standards |
|
Loss on drying |
≤1.0% |
|
Water |
≤1.0% |
|
Inorganic salt |
≤0.1% |
|
Heavy metals |
≤10 ppm |
|
Assay |
99.0%~101.0%(According to EP/USP/BP standards) |
|
Microbiological Analysis |
||
Total plate count |
≤1000cfu/g |
|
Yeast and Moulds |
≤100cfu/g |
|
E. Coli. |
Absent |
|
Salmonella |
Absent |
|
S.aureus |
Absent |
Shelf Life | 2 years |
Stock | In stock |
Packaging | 25kgs/Drum |
Certification | GMP/DMF/ISO |
Test standard | EP/USP/BP |
Test Method | HPLC/UV |
Assay Result | 99.0%~101.0% |
Application:
Anti-anemia drugs. For iron deficiency anemia.
Adverse reactions and contraindications After the injection of this product, hemoglobin did not increase gradually, and should be discontinued. Liver and kidney dysfunction are hanged.
Blood volume supplements.
Adverse reactions and contraindications Occasional allergic reactions. Patients with congestive heart failure and bleeding disorders should be banned, and those with heart, liver and kidney dysfunction should be used with caution.
The medium molecular dextran is mainly used to increase plasma volume and maintain blood pressure, mainly anti-shock. It is suitable for supplementing blood volume and maintaining blood pressure when a large amount of blood is lost. Hemorrhagic such as burns, trauma, trauma, etc. and first aid caused by excessive blood loss. Low molecular dextran, mainly to improve microcirculation, to prevent or eliminate intravascular red blood cell aggregation and thrombosis. The action and use of small molecule dextran is similar to that of a low molecular dextran machine.
CAS NO:52190-28-0
CAS NO:12629-01-5
CAS NO:7331-52-4
CAS NO:301-02-0
CAS NO:613-93-4
CAS NO:1643-19-2
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View